Arif AYDIN

Arif AYDIN


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

18 March 2021 in World Journal of Urology
Verified
Journal Article
Closed access
PDF file
YGYunus Emre Göger
Yunus Emre Göger
MOMEHMET SERKAN OZKENT
MEHMET SERKAN OZKENT
MKMuzaffer Tansel Kılınç
Muzaffer Tansel Kılınç
HTHakan Hakkı Taşkapu
Hakan Hakkı Taşkapu
EGEsra Göger
Esra Göger
GKGiray Karalezli
Giray Karalezli

1 July 2020 in Urology
Verified
Journal Article
Closed access
AAArif AYDIN
Arif AYDIN
MSMehmet Giray Sönmez
Mehmet Giray Sönmez
POPembe Oltulu
Pembe Oltulu
RKRahim Kocabaş
Rahim Kocabaş
LSLeyla Öztürk Sönmez
Leyla Öztürk Sönmez
MBMehmet Balasar
Mehmet Balasar

19 June 2020 in Indian Journal of Surgery
Verified
Journal Article
Closed access
PDF file
AAAdeviye Elçi Atılgan
Adeviye Elçi Atılgan
AAArif AYDIN
Arif AYDIN

1 August 2021 in Journal of Pediatric Urology
Verified
Journal Article
Closed access
AAArif AYDIN
Arif AYDIN
MSMehmet Giray Sönmez
Mehmet Giray Sönmez
GEGökhan Ecer
Gökhan Ecer
FKFahriye Kılınç
Fahriye Kılınç
RKRahim Kocabas
Rahim Kocabas
MBMehmet Balasar
Mehmet Balasar

10 October 2020
Verified
Journal Article
Closed access
AAArif AYDIN
Arif AYDIN
MSMehmet Giray Sönmez
Mehmet Giray Sönmez
POPembe Oltulu
Pembe Oltulu
RKRahim Kocabas
Rahim Kocabas
LSLeyla Ozturk Sonmez
Leyla Ozturk Sonmez
MBMehmet Balasar
Mehmet Balasar
To determine the efficacy of instillation frequency and submucosal injection of platelet-rich plasma (PRP) after urethral trauma to prevent urethral inflammation and spongiofibrosis. Sixty-five rats were used in the study; 50 rats were randomized into 5 groups with 10 rats in each group and 15 rats were allocated for PRP preparation. The urethras of all rats were traumatized with a pediatric urethrotome knife at 6 and 12 o'clock positions, except in the sham group. Group 1 was the sham group and had only urethral catheterization daily for 15 days, Group 2 was given 0.9% saline (physiologic saline [(UI+PS]) once a day after urethral injury (UI+ PS), Group 3 was injected with PRP submucosally after urethral injury, Group 4 was given PRP once a day as intraurethral instillation using a 22 Ga catheter sheath with urethral injury, and Group 5 was given PRP twice a day as intraurethral instillation using a 22 Ga catheter sheath with urethral injury. Each administration of PRP was administered as 300 million platelets/150 microliters. On day 15, the penises of the rats were degloved to perform penectomy. Histopathologic evaluation was made for spongiofibrosis, inflammation, and congestion in vascular structures. When the sham group, UI+PS, UI+PRPx1, UI+PRPx2 and UI+PRPs groups are compared in total, there were significant differences identified for parameters other than edema. When the UI+PS, UI+PRPx1, UI+PRPx2 and UI+PRPs groups are compared, the UI+PS group was observed to have significantly more inflammation (mucosal inf. 2.42 ± 0.53) and spongiofibrosis (2.42 ± 0.53). All the PRP groups were identified to have significantly less mucosal inflammation (UI+PRPs 1 ± 0, UI + PRPx1; 1.4 ± 0.51, PRPx2; 1.33 ± 0.5) and spongiofibrosis (UI+PRPs; 1.57 ± 0.53, PRPx1; 1.2 ± 0.42, PRPx2; 1.55 ± 0.52). The group with the lowest spongiofibrosis was the PRPx1 group. This study showed that PRP significantly reduced mucosal inflammation and spongiofibrosis, independent of the administration route, when applied to the urethra after urethral trauma.